Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis.

Zhang, Chunyu; Hu, Jiao; Li, Huihuang; Ma, Hongzhi; Othmane, Belaydi; Ren, Wenbiao; Yi, Zhenglin; Qiu, Dongxu; Ou, Zhenyu; Chen, Jinbo; Zu, Xiongbing

Zhang, Chunyu; Hu, Jiao; Li, Huihuang; Ma, Hongzhi; Othmane, Belaydi; Ren, Wenbiao; Yi, Zhenglin; Qiu, Dongxu; Ou, Zhenyu; Chen, Jinbo; Zu, Xiongbing.

Afiliação

Zhang C; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Hu J; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Li H; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Ma H; Department of Radiation Oncology, Hunan Cancer Hospital, Central South University, Changsha, China.
Othmane B; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Ren W; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Yi Z; George Whipple Lab for Cancer Research, University of Rochester Medical Institute, Rochester, NY, United States.
Qiu D; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Ou Z; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Chen J; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Zu X; Department of Urology, Xiangya Hospital, Central South University, Changsha, China.

Front Oncol ; 11: 648968, 2021.

Article em En | MEDLINE | ID: mdl-33869048

Palavras-chave

biomarkers; bladder cancer; lymph node metastasis; oncogenes; tumor suppressor genes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google